Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

Healthcare Biotechnology

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

Add To Watchlist

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > FDA filing

View:

Post by goldtech on Nov 25, 2022 5:37pm

FDA filing

Soon the filing for PMN310 will be released and phase 1a will start. This will show toxicity and we know by the primate study that it will be negligible. This step will take us to 1B where all the excitement resides. I laugh at those that say to sell because why would they care, the answer is they can't buy back in. Tough luck.

281

Comment

Comment by DarylTheFrog on Nov 25, 2022 7:09pm

I keep on adding at these levels.I think this will be a great pick ver the next year

109

Comment

Comment by Speyeder999 on Nov 26, 2022 4:34pm

Am counting on the submission for the IND application before years' end but dunno anymore. Gene mentioned back in October with the 7.4 million financing that they were anticipating doing it before years end. No mention of that though unfortunately in their third quarter financial report and in their recent corpotate update which leads me to believe the application will have to wait to ...more

181

Comment

Comment by BottomBroker on Nov 28, 2022 11:21am

Cautiously optimistic that the IND will be filed by year-end. Also interested to see what comes out of the conference in San Francisco this week. Let's all keep our fingers crossed for some real progress over the next year.

129

Comment